CompletedNot Applicable

The Impact of Continuous Transcutaneous CO2 (TCCO2) Monitoring in Extremely Low Birth Weight (ELBW) Infants

Israel166 participantsStarted 2018-01-01

Plain-language summary

An observational study comparing outcomes of Extremely Low Birth Weight (ELBW) infants that were monitored with non-invasive Transcutaneous CO2 (TCCO2) monitor to infants that were not monitored by TCCO2 monitor.

Who can participate

Age range0 Minutes – 24 Hours

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ELBW infants Need of respiratory support Exclusion Criteria: * Parental refusal IVH before study entry chromosomal abnormalities congenital central nervous system (CNS) abnormalities

What they're measuring

IVH-Intraventricular Hemorrhage

Timeframe: Repeated scans until infant reaches corrected age of 42 weeks

PVL- Periventricular Leukomalacia

Timeframe: Repeated scans until infant reaches corrected age of 42 weeks

Trial details

NCT IDNCT03477708

SponsorRambam Health Care Campus

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-04-01

View on ClinicalTrials.gov More ELBW - Extremely Low Birth Weight Infant trials